Literature DB >> 2179631

Dormancy and breast cancer.

A Meltzer1.   

Abstract

A case is presented in which multiple nodules of recurrent cancer appeared about the scar 25 years after radical mastectomy. They were accompanied by an inflammatory reaction. Breast cancers may recur as long as 50 years after surgery. Such late recurrence is accomplished by the cancer cell entering a "dormant" state in which little or no de novo DNA transcription occurs and only enough RNA is translated into proteins to maintain the vegetative functions that sustain cell viability. Features favoring the evolvement of dormancy are discussed as well as the nature of the cocoon-like shell which affords such cancer cells protection from the host's cellular and serological defenses. Speculation, promoted by the new cellular biology, as to the cause of secondary inflammatory cancers, is presented. A possible mechanism for the reactivation of these quiescent cells is suggested. The altered immune reactions of host and cancer cells provide an explanation for the controversies plaguing surgeons regarding the treatment and prognosis of breast cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2179631     DOI: 10.1002/jso.2930430312

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  23 in total

1.  Late-occurring liver metastases in colorectal cancer.

Authors:  Francisco Rodríguez-Moranta; Antoni Castells; Rosa Miquel; Virginia Piñol; Joan Maurel; Josep Fuster; Antonio M Lacy; Josep M Piqué
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

2.  Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency.

Authors:  Mika Suzuki; Evangeline Sari Mose; Valerie Montel; David Tarin
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  Mathematical model of the role of intercellular signalling in intercellular cooperation during tumorigenesis.

Authors:  S Ghosh; S Elankumaran; I K Puri
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

4.  Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?

Authors:  Tibor Bakács; Jitendra N Mehrishi
Journal:  BMC Cancer       Date:  2010-06-02       Impact factor: 4.430

Review 5.  Angiogenesis, metastasis, and endogenous inhibition.

Authors:  M Kirsch; G Schackert; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 6.  The influence of angiogenesis research on management of patients with breast cancer.

Authors:  J Folkman
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

7.  The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background.

Authors:  Hui-Chuan Sun; Zhao-You Tang; Zeng-Chen Ma; Lun-Xiu Qin; Lu Wang; Qin-Hai Ye; Jia Fan; Zhi-Quan Wu; Xin-Da Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-21       Impact factor: 4.553

Review 8.  Overt bone metastasis and bone marrow micrometastasis of early gastric cancer.

Authors:  Hideyuki Ubukata; Gyou Motohashi; Takanobu Tabuchi; Hiroyuki Nagata; Satoru Konishi; Takafumi Tabuchi
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

9.  A murine model of bone marrow micrometastasis in breast cancer.

Authors:  Barbara O'Kane Murphy; Shantaram Joshi; Anne Kessinger; Elizabeth Reed; J Graham Sharp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

10.  New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms.

Authors:  Michael Retsky
Journal:  Int J Environ Res Public Health       Date:  2009-01-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.